Old Web
English
Sign In
Acemap
>
authorDetail
>
Ozlem Ataman
Ozlem Ataman
Janssen-Cilag
Medicine
Immunology
Bortezomib
Multiple myeloma
Dexamethasone
2
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
2015
British Journal of Haematology
Heinz Ludwig
Richard Greil
Tamas Masszi
Ivan Spicka
Ofer Shpilberg
Roman Hájek
Anna Dmoszynska
Bruno Paiva
Maria Belen Vidriales
Graça Esteves
Anne-Marie Stoppa
Don Robinson
Shalini Chaturvedi
Ozlem Ataman
Christopher Enny
Huaibao Feng
Helgi J K van de Velde
Luisa Viterbo
Show All
Source
Cite
Save
Citations (23)
Retrospective Matched-Pair Analysis Of The Efficacy and Safety Of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients (Pts) With Relapsed Multiple Myeloma (MM)
2013
Blood
Robert Z. Orlowski
Thierry Facon
Pieter Sonneveld
Kenneth C. Anderson
Meral Beksac
Lotfi Benboubker
Huw Roddie
Anna Potamianou
Catherine Couturier
Huaibao Feng
Ozlem Ataman
Helgi van de Velde
Paul G. Richardson
Show All
Source
Cite
Save
Citations (2)
1